Urethral Sphincter Injection of Botulinum Toxin A: A Review of Its Application and Outcomes
- 22 February 2017
- journal article
- review article
- Published by Wiley in LUTS: Lower Urinary Tract Symptoms
- Vol. 10 (2) , 109-115
Abstract
The first reported application of Botulinum toxin‐A (BTX‐A) into the urethral sphincter predates the first documented use in the bladder. The aim of this review is to describe the clinical indications of BTX‐A injection into the urethral sphincter and its clinical efficacy. This review of the literature includes the larger more significant published studies that have reported on this use of BTX‐A. Case reports and articles not published in English were excluded. There have been many published clinical studies describing the use of BTX‐A in the urethral sphincter, four of which are randomized placebo controlled trials. These studies tend to include patients either in urinary retention or with obstructed voiding, both in the neuropathic and non‐neuropathic populations. Studies tend to demonstrate improvements in urodynamic parameters and quality of life after injection. There have been many small clinical studies in this area, however larger placebo‐controlled trials are needed to evaluate this treatment at higher levels of evidence.Keywords
Funding Information
- National Institute for Health Research
- King's College Hospital NHS Foundation Trust
This publication has 24 references indexed in Scilit:
- Transrectal Ultrasound–Guided Transperineal Botulinum Toxin A Injection to the External Urethral Sphincter for Treatment of Detrusor External Sphincter Dyssynergia in Patients With Spinal Cord InjuryArchives of Physical Medicine and Rehabilitation, 2010
- Transperineal Injection of Botulinum Toxin A for Treatment of Detrusor Sphincter Dyssynergia: Localization With Combined Fluoroscopic and Electromyographic GuidanceArchives of Physical Medicine and Rehabilitation, 2009
- Satisfaction with urethral injection of Botulinum Toxin A for detrusor sphincter dyssynergia in patients with spinal cord lesionNeurourology and Urodynamics, 2008
- Placebo controlled, randomised, double blind study of the effects of botulinum A toxin on detrusor sphincter dyssynergia in multiple sclerosis patientsJournal of Neurology, Neurosurgery & Psychiatry, 2005
- Effectiveness of Urethral Injection of Botulinum A Toxin in the Treatment of Voiding Dysfunction after Radical HysterectomyUrologia Internationalis, 2005
- Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethraUrology, 2005
- Botulinum A Toxin Urethral Injection for the Treatment of Lower Urinary Tract DysfunctionJournal of Urology, 2003
- Botulinum A toxin treatment for detrusor-sphincter dyssynergia in spinal cord diseaseSpinal Cord, 1998
- Botulinum A toxin as a treatment of detrusor- sphincter dyssynergia in patients with spinal cord injury: MRI controlled transperineal injectionsJournal of Neurology, Neurosurgery & Psychiatry, 1997
- Botulinum-A Toxin as a Treatment of Detruosor-Sphincter Dyssynergia: A Prospective Study in 24 Spinal Cord Injury PatientsJournal of Urology, 1996